News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,624 Results
Type
Article (2448)
Company Profile (40)
Press Release (36136)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14245)
Career Advice (77)
Deals (2091)
Drug Delivery (9)
Drug Development (4113)
Employer Resources (10)
FDA (433)
Job Trends (768)
News (20289)
Policy (1054)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (145)
Allergies (6)
Alliances (3513)
ALS (4)
Alzheimer's disease (46)
Antibody-drug conjugate (ADC) (19)
Approvals (436)
Artificial intelligence (11)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (478)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (30)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (20)
Cancer (151)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (16)
Cell therapy (50)
Cervical cancer (2)
Clinical research (3198)
Collaboration (95)
Compensation (51)
COVID-19 (180)
CRISPR (7)
C-suite (31)
Cystic fibrosis (2)
Data (123)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (469)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4272)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6097)
Executive appointments (100)
FDA (483)
Featured Employer (3)
Funding (79)
Gene editing (14)
Gene therapy (24)
GLP-1 (60)
Government (149)
Healthcare (704)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (17)
Indications (2)
Infectious disease (185)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (992)
IRA (7)
Job creations (291)
Job search strategy (62)
Kidney cancer (4)
Labor market (4)
Layoffs (39)
Leadership (1)
Legal (212)
Liver cancer (6)
Lung cancer (15)
Lymphoma (5)
Management (4)
Manufacturing (21)
MASH (4)
Medical device (309)
Medtech (309)
Mergers & acquisitions (1174)
Metabolic disorders (34)
Multiple sclerosis (9)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (94)
NextGen: Class of 2025 (354)
Non-profit (153)
Northern California (388)
Now hiring (4)
Obesity (16)
Opinion (15)
Ovarian cancer (11)
Pain (10)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (24)
Patient recruitment (5)
Peanut (1)
People (5728)
Pharmaceutical (5)
Phase I (1379)
Phase II (1603)
Phase III (852)
Pipeline (84)
Policy (12)
Postmarket research (31)
Preclinical (602)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (25)
Real estate (427)
Recruiting (5)
Regulatory (811)
Reports (6)
Research institute (142)
Resumes & cover letters (9)
RNA editing (1)
Schizophrenia (11)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (2)
Southern California (372)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (492)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1823)
Vaccines (28)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (30)
Last 7 days (91)
Last 30 days (264)
Last 365 days (2590)
2025 (868)
2024 (2637)
2023 (2875)
2022 (3766)
2021 (4061)
2020 (3484)
2019 (2066)
2018 (1560)
2017 (1809)
2016 (1640)
2015 (1864)
2014 (1385)
2013 (1198)
2012 (1409)
2011 (1351)
2010 (1206)
Location
Africa (43)
Alabama (1)
Arizona (15)
Asia (1905)
Australia (298)
California (885)
Canada (138)
China (41)
Colorado (21)
Connecticut (11)
Delaware (4)
Europe (3925)
Florida (44)
Georgia (6)
Idaho (3)
Illinois (14)
India (1)
Indiana (33)
Japan (7)
Kansas (12)
Maryland (26)
Massachusetts (319)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (6)
New Hampshire (2)
New Jersey (71)
New York (50)
North Carolina (91)
Northern California (388)
Ohio (26)
Oklahoma (2)
Oregon (5)
Pennsylvania (54)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (372)
Tennessee (2)
Texas (74)
Utah (3)
Virginia (6)
Washington D.C. (1)
Washington State (54)
Wisconsin (6)
38,624 Results for "xcell biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Xcell Biosciences and Royal Perth Hospital to Develop Next Gen Automated TIL Manufacturing Workflow
March 19, 2025
·
3 min read
Biotech Bay
Xcell Biosciences to Showcase Future of Cell Manufacturing at ISCT 2024
Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing applications, today announced its speaker lineup and activities for the upcoming ISCT 2024, the annual meeting of the International Society for Cell & Gene Therapy, taking place May 29 – June 1 in Vancouver, British Columbia.
May 22, 2024
·
2 min read
Business
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
Xcell Biosciences Inc. today announced it has added new elements to its research collaboration agreement with Labcorp, a global leader of innovative and comprehensive laboratory services.
April 1, 2024
·
4 min read
Biotech Bay
AmplifyBio and Xcell Biosciences Announce Partnership to Manufacture Solid Tumor-Targeting TCR-T Cell Therapy
Xcell Biosciences Inc. and AmplifyBio today announced the launch of a partnership designed to streamline and improve the manufacturing process for engineered T-cell receptor (TCR) therapies targeting solid tumors.
May 20, 2024
·
4 min read
Business
Xcell Biosciences Announces New Scientific and Business Advisory Board
Xcell Biosciences Inc., an instrumentation company focused on cell and gene therapy applications, announced the formation of a new scientific and business advisory board composed of some of the leading minds in the industry.
March 27, 2024
·
4 min read
Press Releases
Xcell Biosciences Expands AmplifyBio Collaboration with Unique Cell and Gene Therapy Manufacturing Capabilities
October 2, 2024
·
3 min read
Business
Xcell Biosciences Announces Collaboration with ElevateBio to Advance Technology Development for Cell and Gene Therapies
Xcell Biosciences, Inc. today announced a collaboration with ElevateBio, LLC (ElevateBio), through which the companies aim to explore novel approaches to improving therapeutic potency of cell and gene therapies.
January 11, 2024
·
3 min read
Press Releases
NewBiologix Launches Xcell™ rAAV Production and Analytics Platform to Improve and Accelerate Gene Therapy Development
November 21, 2024
·
2 min read
Press Releases
NewBiologix Launches Xcell™ to Accelerate, Optimize, and Scale Gene and Cell Therapy Production
October 31, 2024
·
2 min read
Business
Xcell Biosciences and Labcorp Achieve Key Data Milestones in Cell and Gene Therapy Collaboration
Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has achieved key milestones in its R&D collaboration with Labcorp, a global leader of innovative and comprehensive laboratory services, aimed at driving innovation in the development and validation of cell and gene therapies.
August 24, 2023
·
3 min read
1 of 3,863
Next
